Transaction in Own Shares - Replacement
Summary by AI BETAClose X
10 August 2026
Correction to the shares held in treasury (with no voting rights) figure.
METLEN Energy & Metals PLC
(the "Company")
Transaction in own shares
The Company announces that, in accordance with the terms of its share buyback programme announced on 23 June 2026, during the period from 3 August 2026 to 7 August 2026 (inclusive) (the "Disclosure Period"), it purchased the following number of its ordinary shares of €1.00 each through Piraeus Securities S.A.:
|
Date within Disclosure Period |
Trading Venue |
Aggregate number of ordinary shares repurchased |
Lowest price paid (per ordinary share, in euro) |
Highest price paid (per ordinary share, in euro) |
Volume-weighted average price (per ordinary share, in euro) |
|
3 August 2026 |
Euronext Athens |
25.000 |
46,26 |
46,94 |
46,7610 |
|
4 August 2026 |
Euronext Athens |
15.000 |
46,96 |
46,98 |
46,9799 |
|
5 August 2026 |
Euronext Athens |
0 |
- |
- |
- |
|
6 August 2026 |
Euronext Athens |
30.000 |
48,46 |
48,46 |
48,4600 |
|
7 August 2026 |
Euronext Athens |
30.000 |
48,32 |
48,32 |
48,3200 |
These shares will be held in Treasury.
Following these purchases and the disposal of 7,611 treasury shares to a beneficiary, at no consideration, on the vesting of awards granted to them under the Company's long-term incentive plan, the Company's share capital comprises:
Total issued share capital: 143.426.244
Shares held in treasury (with no voting rights): 705,224
Total voting rights: 142,721,020
For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should exclude any shares held in treasury and should use the figure of 142.721.020 as the denominator for the calculations when determining if they are required to notify their interest in. or a change to their interest in the Company.
LEI - 213800ZSR3HVKMMPVG86
For further information. please contact:
Investor Relations
Tel. +30 210-6877300 | Fax +30 210-6877400 | E-mail: ir@metlen.com
Press Office
Tel. +30 210-6877346 | Fax +30 210-6877400 | E-mail: communications@metlen.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 13 minutes ago City of London Investment Group
- 20 minutes ago BioPharma Credit
- 24 minutes ago BioPharma Credit
- 25 minutes ago Diageo
- 29 minutes ago Barr (A.G.)